James F. Reddoch - Net Worth and Insider Trading

James F. Reddoch Net Worth

The estimated net worth of James F. Reddoch is at least $24 Million dollars as of 2024-04-27. James F. Reddoch is the EVP & Chief Scientific Officer of Royalty Pharma PLC and owns about 845,830 shares of Royalty Pharma PLC (RPRX) stock worth over $24 Million. Details can be seen in James F. Reddoch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James F. Reddoch has not made any transactions after 2022-09-28 and currently still holds the listed stock(s).

Transaction Summary of James F. Reddoch

To

James F. Reddoch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James F. Reddoch owns 1 companies in total, including Royalty Pharma PLC (RPRX) .

Click here to see the complete history of James F. Reddoch’s form 4 insider trades.

Insider Ownership Summary of James F. Reddoch

Ticker Comapny Transaction Date Type of Owner
RPRX Royalty Pharma PLC 2022-09-28 EVP & Research & Investments

James F. Reddoch Latest Holdings Summary

James F. Reddoch currently owns a total of 1 stock. James F. Reddoch owns 845,830 shares of Royalty Pharma PLC (RPRX) as of September 28, 2022, with a value of $24 Million.

Latest Holdings of James F. Reddoch

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPRX Royalty Pharma PLC 2022-09-28 845,830 28.00 23,683,240

Holding Weightings of James F. Reddoch


James F. Reddoch Form 4 Trading Tracker

According to the SEC Form 4 filings, James F. Reddoch has made a total of 13 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Royalty Pharma PLC is the sale of 100,000 shares on September 28, 2022, which brought James F. Reddoch around $4 Million.

Insider Trading History of James F. Reddoch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James F. Reddoch Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James F. Reddoch Ownership Network

Ownership Network List of James F. Reddoch

No Data

Ownership Network Relation of James F. Reddoch


James F. Reddoch Owned Company Details

What does Royalty Pharma PLC do?

Who are the key executives at Royalty Pharma PLC?

James F. Reddoch is the EVP & Research & Investments of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .

Royalty Pharma PLC (RPRX) Insider Trades Summary

Over the past 18 months, James F. Reddoch made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 420,000 shares made by George W. Lloyd , a net sale of 2,479,950 shares made by Rory B Riggs , and a net purchase of 600,000 shares made by Pablo G. Legorreta .

In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.

Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Royalty Pharma PLC Insider Transactions

No Available Data

James F. Reddoch Mailing Address

Above is the net worth, insider trading, and ownership report for James F. Reddoch. You might contact James F. Reddoch via mailing address: C/o Royalty Pharma Plc, 110 East 59th Street, New York Ny 10022.

Discussions on James F. Reddoch

No discussions yet.